Cas:1627-06-1 Anthracene photodimer manufacturer & supplier

Chemical Name:Anthracene photodimer

CAS.NO:1627-06-1

Synonyms:Dianthracene;Anthracene,dimer;5,6,11,12-Tetrahydro-5,12,6,11-di-o-benzeno-dibenzo[a,e]cycloocten;5,6,11,12-tetrahydro-5,12,6,11-di-o-benzeno-dibenzo[a,e]cyclooctene

Molecular Formula:C₂₈H₂₀

Molecular Weight:356.45800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:409.8ºC at 760mmHg

Density:1.211g/cm3

Index of Refraction:1.693

PSA:

Exact Mass:356.15700

LogP:6.55480

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Dianthracene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5,6,11,12-tetrahydro-5,12,6,11-di-o-benzeno-dibenzo[a,e]cyclooctene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dianthracene Use and application,Anthracene,dimer technical grade,usp/ep/jp grade.

Related News: Just last week, the CDC updated J&J’s label again to warn of “an increased risk” for GBS, although the agency has maintained that a definitive link hasn’t been established. Europe’s medicines regulator added its own warning on Thursday just ahead of ACIP’s meeting. 1,2-Bis(difluoromethoxy)benzene manufacturers Except current data is insufficient to determine its benefit in patients who are negative for anti-AChR antibodies. 2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane suppliers Except current data is insufficient to determine its benefit in patients who are negative for anti-AChR antibodies. 6-Bromo-5-nitroquinoline vendor & factory Grégoire then joined telecoms service provider Cirpack, following its acquisition of Andrexen, as Chief Marketing and Product Officer. He most recently held the position of Chief Strategy Officer at Experty.io, a blockchain-based knowledge sharing platform.,Just last week, the CDC updated J&J’s label again to warn of “an increased risk” for GBS, although the agency has maintained that a definitive link hasn’t been established. Europe’s medicines regulator added its own warning on Thursday just ahead of ACIP’s meeting.